Key Details of Rescheduled Event

  • The earnings conference call to discuss Q2 FY 2026-27 financial results has been rescheduled from 5:00 PM IST to 4:00 PM IST on Thursday, October 29, 2026.
  • This is a continuation of the company's earlier intimation dated October 22, 2026.

Management Participants

The conference call will feature the following management speakers from Senores Pharmaceuticals:

  • Mr. Swapnil Shah – Promoter and Managing Director
  • Mr. Sanjay Majmudar – Chairman
  • Mr. Deval Shah – Whole Time Director and Chief Financial Officer

Call Arrangements

  • DAM Capital Advisors Ltd is organizing the earnings call
  • Nitin Agarwal, Analyst at DAM Capital Advisors, will lead the call
  • Universal access numbers: +91 22 6280 1384 and +91 22 7115 8285 (accessible from all networks and countries)
  • International toll-free numbers provided for Hong Kong, Singapore, UK, and USA
  • Participants are advised to dial in 5-10 minutes prior to the scheduled time

Post-Call Information

  • The audio recording and transcript of the call will be published on the company's website
  • The company will intimate stakeholders about the availability of these materials